Primary immunodeficiency due to a defect in adaptive immunity

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:179006
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Primary immunodeficiency due to a defect in adaptive immunity is a broad category of inherited immune system disorders (Orphanet code 179006) in which the body's adaptive immune system — comprising T lymphocytes, B lymphocytes, or both — fails to function properly. This group encompasses a wide range of specific conditions, including severe combined immunodeficiencies (SCID), combined immunodeficiencies, predominantly antibody deficiencies, and other disorders where the specialized, antigen-specific arm of the immune response is impaired. Because adaptive immunity is essential for targeted defense against infections and for immunological memory, patients with these conditions are highly susceptible to recurrent, severe, and often unusual infections caused by bacteria, viruses, fungi, and opportunistic organisms. The clinical presentation varies depending on the specific underlying defect but commonly includes recurrent sinopulmonary infections, chronic diarrhea, failure to thrive in infants and children, skin infections, and susceptibility to opportunistic pathogens. Some patients may also develop autoimmune manifestations, lymphoproliferation, or an increased risk of malignancy. The severity ranges from life-threatening conditions presenting in the neonatal period (such as SCID) to milder antibody deficiencies that may not be diagnosed until adulthood. Treatment depends on the specific diagnosis and severity. Immunoglobulin replacement therapy is a cornerstone for antibody deficiencies. Prophylactic antimicrobials are frequently used to prevent infections. For severe forms, particularly SCID and certain combined immunodeficiencies, hematopoietic stem cell transplantation (HSCT) is the definitive curative treatment. Gene therapy has emerged as a therapeutic option for select conditions. Supportive care, infection surveillance, and avoidance of live vaccines are important management strategies across this disease group.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Primary immunodeficiency due to a defect in adaptive immunity.

View clinical trials →

No actively recruiting trials found for Primary immunodeficiency due to a defect in adaptive immunity at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Primary immunodeficiency due to a defect in adaptive immunity community →

No specialists are currently listed for Primary immunodeficiency due to a defect in adaptive immunity.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Primary immunodeficiency due to a defect in adaptive immunity.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Primary immunodeficiency due to a defect in adaptive immunityForum →

No community posts yet. Be the first to share your experience with Primary immunodeficiency due to a defect in adaptive immunity.

Start the conversation →

Latest news about Primary immunodeficiency due to a defect in adaptive immunity

1 articles
ResearchPUBMEDMar 26, 2026
Diagnostic odyssey of patients with the rare immunodeficiency activated PI3 kinase delta syndrome (APDS): case study from expert and patient surveys.
This study looked at how long it takes to diagnose APDS, a very rare immune system disorder that affects only 1-2 people per million. Researchers interviewed pa
See all news about Primary immunodeficiency due to a defect in adaptive immunity

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Primary immunodeficiency due to a defect in adaptive immunity

What is Primary immunodeficiency due to a defect in adaptive immunity?

Primary immunodeficiency due to a defect in adaptive immunity is a broad category of inherited immune system disorders (Orphanet code 179006) in which the body's adaptive immune system — comprising T lymphocytes, B lymphocytes, or both — fails to function properly. This group encompasses a wide range of specific conditions, including severe combined immunodeficiencies (SCID), combined immunodeficiencies, predominantly antibody deficiencies, and other disorders where the specialized, antigen-specific arm of the immune response is impaired. Because adaptive immunity is essential for targeted def